NCT07570082
Drug-Drug Interaction Study of Atumelnant in Healthy Participants
Completed
PHASE1Ages 19–55InterventionalTreatmentCrinetics Pharmaceuticals Inc.
~46 participants
Updated 2026-08-19 on ClinicalTrials.gov
What's tested:AtumelnantCarbamazepineMidazolamDigoxinMetformin
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cohort 1: Pharmacokinetics (AUC 0-last)
Measured over Up to Day 34
+5 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesNebraska1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Cohort 1: Pharmacokinetics (AUC 0-last)Up to Day 34
- Cohort 1: Pharmacokinetics (AUC 0-inf)Up to Day 34
- Cohort 1: Pharmacokinetics (Cmax)Up to Day 34
- Cohort 2: Pharmacokinetics (AUC 0-last)Up to Day 21
- Cohort 2: Pharmacokinetics (AUC 0-inf)Up to Day 21
- Cohort 2: Pharmacokinetics (Cmax)Up to Day 21